162 related articles for article (PubMed ID: 38625857)
1. Biophysical characterization of the CXC chemokine receptor 2 ligands.
Martin P; Kurth EA; Budean D; Momplaisir N; Qu E; Simien JM; Orellana GE; Brautigam CA; Smrcka AV; Haglund E
PLoS One; 2024; 19(4):e0298418. PubMed ID: 38625857
[TBL] [Abstract][Full Text] [Related]
2. Cell surface heparan sulfate participates in CXCL1-induced signaling.
Wang D; Sai J; Richmond A
Biochemistry; 2003 Feb; 42(4):1071-7. PubMed ID: 12549928
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
[TBL] [Abstract][Full Text] [Related]
4. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
[TBL] [Abstract][Full Text] [Related]
5. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
[TBL] [Abstract][Full Text] [Related]
7. Discrete steps in binding and signaling of interleukin-8 with its receptor.
Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide N-oxides as CXCR2 antagonists.
Cutshall NS; Ursino R; Kucera KA; Latham J; Ihle NC
Bioorg Med Chem Lett; 2001 Jul; 11(14):1951-4. PubMed ID: 11459668
[TBL] [Abstract][Full Text] [Related]
9. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
Yang W; Schraw WP; Mueller SG; Richmond A
Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
[TBL] [Abstract][Full Text] [Related]
10. Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection.
Moore TA; Newstead MW; Strieter RM; Mehrad B; Beaman BL; Standiford TJ
J Immunol; 2000 Jan; 164(2):908-15. PubMed ID: 10623839
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
[TBL] [Abstract][Full Text] [Related]
12. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.
Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K
J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874
[TBL] [Abstract][Full Text] [Related]
13. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist.
Nicholls DJ; Wiley K; Dainty I; MacIntosh F; Phillips C; Gaw A; Mårdh CK
J Pharmacol Exp Ther; 2015 May; 353(2):340-50. PubMed ID: 25736418
[TBL] [Abstract][Full Text] [Related]
15. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
[TBL] [Abstract][Full Text] [Related]
16. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.
Ludwig A; Petersen F; Zahn S; Götze O; Schröder JM; Flad HD; Brandt E
Blood; 1997 Dec; 90(11):4588-97. PubMed ID: 9373270
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
Katancik JA; Sharma A; de Nardin E
Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.
Ravindran A; Sawant KV; Sarmiento J; Navarro J; Rajarathnam K
J Biol Chem; 2013 Apr; 288(17):12244-52. PubMed ID: 23479735
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.
Van den Steen PE; Proost P; Wuyts A; Van Damme J; Opdenakker G
Blood; 2000 Oct; 96(8):2673-81. PubMed ID: 11023497
[TBL] [Abstract][Full Text] [Related]
20. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
